title: Are we "ONTARGET" yet with regard to optimal antihypertensive regimens?
authors.forename: Matthew R
authors.initials: MR
authors.lastname: Weir
references.citation: N Engl J Med. 1992 Sep 3;327(10):669-77
references.pmid: 1386652
references.citation: N Engl J Med. 1991 Aug 1;325(5):293-302
references.pmid: 2057034
references.citation: Curr Opin Nephrol Hypertens. 2000 Jul;9(4):403-11
references.pmid: 10926177
references.citation: N Engl J Med. 2003 Nov 13;349(20):1893-906
references.pmid: 14610160
references.citation: N Engl J Med. 2001 Dec 6;345(23):1667-75
references.pmid: 11759645
references.citation: Lancet. 2000 Jan 22;355(9200):253-9
references.pmid: 10675071
references.citation: Lancet. 2003 Sep 6;362(9386):772-6
references.pmid: 13678870
references.citation: N Engl J Med. 2000 Jan 20;342(3):145-53
references.pmid: 10639539
references.citation: N Engl J Med. 2008 Apr 10;358(15):1547-59
references.pmid: 18378520